Contraline is developing a non-hormonal, long-lasting, and reversible male contraceptive device. This minimally invasive solution offers men an effective and sustainable option for family planning.
Funding
Funding not disclosed
Founders
Product
Problem
Current male contraceptive options are limited, with most relying on condoms or vasectomy. Many men are excluded from reproductive decisions due to the lack of convenient, hormone-free, and reversible alternatives. This creates an imbalance in family planning responsibilities.
Solution
MTology Innovations is developing EMIT, a non-hormonal male contraceptive designed to be repeatable and reversible. EMIT aims to empower men with more control over their reproductive health, offering a natural alternative to existing methods. The solution provides men the option to suspend their fertility without the long-term commitment of a vasectomy or the potential side effects associated with hormonal treatments. By offering a convenient and reversible option, MTology Innovations seeks to promote equality in reproductive health choices.
Target Audience
The primary target audience is men who desire more control over their reproductive health and are seeking non-hormonal, reversible contraceptive options.
Features
- Non-hormonal mechanism of action
- Reversible suspension of fertility
- Repeatable use for on-demand contraception
- Designed to empower men in family planning decisions
- Aims to provide a natural alternative to existing contraceptive methods